advertisement

Topcon

Ophthalmology 118

Showing records 1 to 25 | Display all abstracts in Ophthalmology

98707 Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis
Stuart KV
Ophthalmology 2022; 129: 637-652
98602 Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study
Singer MA
Ophthalmology 2022; 129: 605-613
98964 Long term outcomes from the HORIZON randomized trial for a Schlemm's canal microstent in combination cataract and glaucoma surgery
Ahmed IIK
Ophthalmology 2022; 129: 742-751
99142 Six-year incidence and risk factors for primary angle closure disease: The Singapore Epidemiology of Eye Diseases Study
Teo ZL
Ophthalmology 2022; 129: 792-802
99111 Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Lin F
Ophthalmology 2022; 129: 803-812
98996 Punctal Stenosis Associated with Topical Netarsudil Use
Meirick TM
Ophthalmology 2022; 129: 765-770
98928 Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging
Kihara Y
Ophthalmology 2022; 129: 781-791
98535 Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in its Development
Simcoe MJ
Ophthalmology 2022; 129: 626-636
98200 Foundational Considerations for Artificial Intelligence Using Ophthalmic Images
Abràmoff MD
Ophthalmology 2022; 129: e14-e32
99166 Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis
Zhong Z
Ophthalmology 2022; 129: 821-828
98219 Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Zafar S
Ophthalmology 2022; 129: 250-257
99244 Corneal endothelial cell density loss following glaucoma surgery alone or in combination with cataract surgery: A systematic review and meta-analysis
Fang CE
Ophthalmology 2022; 129: 841-855
99142 Six-year incidence and risk factors for primary angle closure disease: The Singapore Epidemiology of Eye Diseases Study
Da Soh Z
Ophthalmology 2022; 129: 792-802
99111 Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change
Chen S
Ophthalmology 2022; 129: 803-812
98964 Long term outcomes from the HORIZON randomized trial for a Schlemm's canal microstent in combination cataract and glaucoma surgery
De Francesco T
Ophthalmology 2022; 129: 742-751
98928 Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging
Montesano G
Ophthalmology 2022; 129: 781-791
98535 Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in its Development
Shah A
Ophthalmology 2022; 129: 626-636
98996 Punctal Stenosis Associated with Topical Netarsudil Use
Mudumbai RC
Ophthalmology 2022; 129: 765-770
99244 Corneal endothelial cell density loss following glaucoma surgery alone or in combination with cataract surgery: A systematic review and meta-analysis
Mathew RG
Ophthalmology 2022; 129: 841-855
98707 Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis
Madjedi K
Ophthalmology 2022; 129: 637-652
98602 Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study
Sheth V
Ophthalmology 2022; 129: 605-613
99166 Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis
Ding J
Ophthalmology 2022; 129: 821-828
98219 Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019
Dun C
Ophthalmology 2022; 129: 250-257
98602 Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study
Sheth V
Ophthalmology 2022; 129: 605-613
98200 Foundational Considerations for Artificial Intelligence Using Ophthalmic Images
Cunningham B
Ophthalmology 2022; 129: e14-e32

Issue 22-4

Change Issue


advertisement

Oculus